The myopia movement

Affiliations

¹ School of Optometry and Vision Science, The University of New South Wales, Sydney, Australia.
² Intensive Care Research Unit, Northern Clinical School, Royal North Shore Hospital, The University of Sydney, Sydney, Australia.

Free article

Editorial

Pauline Kang et al. Clin Exp Optom. 2020 Mar.

Free article

. 2020 Mar;103(2):129-130.

doi: 10.1111/cxo.13040.

¹ School of Optometry and Vision Science, The University of New South Wales, Sydney, Australia.
² Intensive Care Research Unit, Northern Clinical School, Royal North Shore Hospital, The University of Sydney, Sydney, Australia.

No abstract available

Keywords: atropine; multifocal contact lenses; myopia control; orthokeratology.

References

1. Holden BA, Fricke TR, Wilson DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016; 123: 1036-1042.
1. Bourne RR, Stevens GA, White RA et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health 2013; 1: e339-e349.
1. Brennan NA, Cheng X. Commonly held beliefs about myopia that lack a robust evidence base. Eye Contact Lens 2019; 45: 215-225.
1. Chia A, Chua WH, Cheung YB et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 2012; 119: 347-354.
1. Chua WH, Balakrishnan V, Chan YH et al. Atropine for the treatment of childhood myopia. Ophthalmology 2006; 113: 2285-2291.